AL102

· Immunome, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for AL102, covering 2026-02-05 to 2026-06-08. Get the full timeline:

Most recent: Clinical Trial Update: A Study of AL102 in Patients With Progressing Desmoid Tumors [Phase 2, Phase 3]